Skip to main content
C4 Therapeutics, Inc. logo

C4 Therapeutics, Inc. — Investor Relations & Filings

Ticker · CCCC ISIN · US12529R1077 US Manufacturing
Filings indexed 497 across all filing types
Latest filing 2020-11-12 Earnings Release
Country US United States of America
Listing US CCCC

About C4 Therapeutics, Inc.

https://c4therapeutics.com/

C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of a new class of small-molecule medicines through targeted protein degradation (TPD). The company's proprietary TORPEDO (Target Oriented Protein Degrader Optimizer) platform is utilized to create therapeutics that selectively destroy disease-causing proteins. C4 Therapeutics' primary focus is on developing treatments for cancer and other diseases. Its clinical pipeline includes investigational candidates such as cemsidomide (CFT7455) for hematologic malignancies, CFT8919 for solid tumors with specific genetic mutations, and CFT1946 for BRAF V600 mutant cancers.

Recent filings

Filing Released Lang Actions
8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 12, 2020, by C4 Therapeutics, Inc. It announces the issuance of a press release containing financial results and business highlights for the quarter and year ended September 30, 2020. The document itself does not contain detailed financial statements or substantive financial data but rather furnishes the press release as an exhibit. The length of the document is 3752 characters, which is relatively short and consistent with an announcement rather than a full report. According to the rules, such a document that announces the release of financial results but does not contain the full report itself should be classified as an Earnings Release (ER).
2020-11-12 English
SC 13D
Major Shareholding Notification
2020-10-16 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-10-16 English
FORM 4 SUBMISSION
Director's Dealing
2020-10-07 English
FORM 4 SUBMISSION
Director's Dealing
2020-10-07 English
FORM 4 SUBMISSION
Director's Dealing
2020-10-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.